A literature review of the patent application publications on cabotegravir - an HIV integrase strand transfer inhibitor
{{output}}
Introduction: Studies presented in the patent applications demonstrate that a new integrase strand transfer inhibitor cabotegravir might be used as long-acting antiretroviral formulation or delivery system that reduces dosing frequency and may therefore increa... ...
